EA201270581A1 - Фармацевтические композиции севеламера - Google Patents

Фармацевтические композиции севеламера

Info

Publication number
EA201270581A1
EA201270581A1 EA201270581A EA201270581A EA201270581A1 EA 201270581 A1 EA201270581 A1 EA 201270581A1 EA 201270581 A EA201270581 A EA 201270581A EA 201270581 A EA201270581 A EA 201270581A EA 201270581 A1 EA201270581 A1 EA 201270581A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sevelamera
pharmaceutical compositions
core
tablets
medicine
Prior art date
Application number
EA201270581A
Other languages
English (en)
Other versions
EA024699B1 (ru
Inventor
Нильс Яп Осинга
Original Assignee
Синтон Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синтон Б.В. filed Critical Синтон Б.В.
Publication of EA201270581A1 publication Critical patent/EA201270581A1/ru
Publication of EA024699B1 publication Critical patent/EA024699B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к фармацевтической таблетке с немедленным высвобождением, включающей ядро, содержащее 70-85 мас.% севеламера карбоната в пересчете на безводное соединение, 10-25 мас.% лактозы моногидрата и, дополнительно, растворимую в воде пленочную оболочку, окружающую ядро, к способу получения таких таблеток, к их использованию в медицине и к использованию привитого сополимера поливинилового спирта-полиэтиленгликоля для получения таблеток, покрытых оболочкой.
EA201270581A 2009-10-22 2009-10-22 Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат EA024699B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/007586 WO2011047700A1 (en) 2009-10-22 2009-10-22 Pharmaceutical compositions of sevelamer

Publications (2)

Publication Number Publication Date
EA201270581A1 true EA201270581A1 (ru) 2012-12-28
EA024699B1 EA024699B1 (ru) 2016-10-31

Family

ID=42044436

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270581A EA024699B1 (ru) 2009-10-22 2009-10-22 Фармацевтическая таблетка с немедленным высвобождением, содержащая севеламера карбонат

Country Status (7)

Country Link
US (1) US20120219626A1 (ru)
EP (1) EP2490675B1 (ru)
DK (1) DK2490675T3 (ru)
EA (1) EA024699B1 (ru)
ES (1) ES2720869T3 (ru)
WO (1) WO2011047700A1 (ru)
ZA (1) ZA201203719B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
EP3287133B1 (en) 2013-06-05 2019-04-17 Tricida Inc. Proton-binding polymers for oral administration
JP6903576B2 (ja) 2014-12-10 2021-07-14 トリシダ・インコーポレイテッドＴｒｉｃｉｄａ， Ｉｎｃ． 経口投与用プロトン結合ポリマー
US20180015119A1 (en) * 2015-02-23 2018-01-18 Amneal Pharmaceuticals Company Gmbh Process for granulating sevelamer carbonate
CN109414453B (zh) 2016-05-06 2023-02-17 特里赛达公司 用于治疗酸碱失衡的组合物
US11266684B2 (en) 2017-11-03 2022-03-08 Tricida, Inc. Compositions for and method of treating acid-base disorders
CN110664772A (zh) * 2019-09-27 2020-01-10 方达医药技术（苏州）有限公司 一种碳酸司维拉姆片及其制备方法
CN111773190A (zh) * 2020-06-24 2020-10-16 北京瑞迪道森医药科技有限公司 一种提高制剂安全性的碳酸司维拉姆片及其制备方法
CN112220762B (zh) * 2020-09-07 2022-08-19 湖北华世通生物医药科技有限公司 碳酸司维拉姆包衣片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
CZ20021344A3 (cs) * 1999-10-19 2002-08-14 Geltex Pharmaceuticals, Inc. Tableta obsahující jádro a potahování a stlačená tableta
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
CA2642255A1 (en) * 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) * 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
US20100008988A1 (en) * 2008-07-14 2010-01-14 Glenmark Generics, Ltd. Tablet compositions of amine polymers

Also Published As

Publication number Publication date
EP2490675B1 (en) 2019-01-23
EP2490675A1 (en) 2012-08-29
WO2011047700A1 (en) 2011-04-28
DK2490675T3 (en) 2019-04-29
EA024699B1 (ru) 2016-10-31
ZA201203719B (en) 2013-08-28
ES2720869T3 (es) 2019-07-25
US20120219626A1 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
EA201270581A1 (ru) Фармацевтические композиции севеламера
AR114143A2 (es) Formulaciones de comprimidos revestidos
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
WO2011101866A3 (en) Gastric retention formulation containing baclofen
MX351584B (es) Formulacion farmaceutica acuosa de tapentadol para administracion oral.
ES2488407T3 (es) Preparación farmacéutica que contiene lipasa de origen bacteriano
EA201170616A1 (ru) Лекарственная форма ацетаминофен/трамадол с замедленным действием для перорального приема
EP3895698A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
CL2012003729A1 (es) Composicion farmaceutica oral que comprende monohidrato de monolactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, uno o mas rellenos, un desintegrante y un lubricante; proceso de preparacion de la composicion.
UY33076A (es) Microcápsulas de fexofenadina y composiciones que las contienen
IN2013MU03658A (ru)
WO2011101863A3 (en) Extended release pharmaceutical compositions of lacosamide
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
MX2012008381A (es) Tira dental para administracion de tratamiento oral.
MX358636B (es) Formulaciones farmacéuticas de naproxeno para la encapsulación en gel blando y combinaciones de las mismas.
UA97971C2 (ru) Препарат невирапина пролонгированного высвобождения
DOP2015000089A (es) Composición de difenidol de liberación prolongada
IT1401284B1 (it) Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system).
EA201490500A1 (ru) Многослойный высвобождающий состав
EA201291276A1 (ru) Фармацевтические композиции, содержащие солифенацин
WO2010099510A3 (en) Amino acid-based compounds, their methods of use, and methods of screening
TR201803451T4 (tr) Olmesartan formülasyonlari.
EA201400740A1 (ru) Фармацевтические композиции севеламера
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM